Christian Mirescu
Company: Vigil Neuroscience
Job title: Vice President, Head of Neuroimmunology
Seminars:
Spotlighting Clinical Trials of TREM2 Agonists Against Alzheimer’s Disease 8:30 am
• Overviewing the on-going clinical landscape of TREM2 therapeutics • Detailing currently employed biomarkers – what they are and what reveal • Outlining high-level modality considerations for rare vs common neurodegenerative diseases • Making the case for precision-based clinical developmentRead more
day: Day One